FDA Inspection 1225980 — Mayo Clinic Rochester, Division of Transfusion Medicine
The FDA completed an inspection of Mayo Clinic Rochester, Division of Transfusion Medicine on November 15, 2023 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 15, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rochester, MN (United States)